These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 15906096)

  • 1. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
    Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE
    Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
    Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
    Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype and linkage disequilibrium architecture for human cancer-associated genes.
    Bonnen PE; Wang PJ; Kimmel M; Chakraborty R; Nelson DL
    Genome Res; 2002 Dec; 12(12):1846-53. PubMed ID: 12466288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potential Genes for Benign Prostatic Hyperplasia and Prostate Cancer Susceptibility in Four X-chromosome Regions with High Frequency of Microvariant Alleles.
    Albujja MH; Messaudi SA; Vasudevan R; Al Ghamdi S; Chong PP; Ghani KA; Ranneh Y; Alaidarous M; Ismail P
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2271-2280. PubMed ID: 32856855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
    Lange EM; Chen H; Brierley K; Perrone EE; Bock CH; Gillanders E; Ray ME; Cooney KA
    Clin Cancer Res; 1999 Dec; 5(12):4013-20. PubMed ID: 10632333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of cancer susceptibility genes by genome-wide single-nucleotide polymorphism linkage-disequilibrium mapping.
    Mitra N; Ye TZ; Smith A; Chuai S; Kirchhoff T; Peterlongo P; Nafa K; Phillips MS; Offit K; Ellis NA
    Cancer Res; 2004 Nov; 64(21):8116-25. PubMed ID: 15520224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.
    Agalliu I; Leanza SM; Smith L; Trent JM; Carpten JD; Bailey-Wilson JE; Burk RD
    Prostate; 2010 Nov; 70(15):1716-27. PubMed ID: 20564318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-scale mapping of a novel dementia gene, PLOSL, by linkage disequilibrium.
    Pekkarinen P; Kestilä M; Paloneva J; Terwillign J; Varilo T; Järvi O; Hakola P; Peltonen L
    Genomics; 1998 Dec; 54(2):307-15. PubMed ID: 9828133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death.
    Nurminen R; Lehtonen R; Auvinen A; Tammela TL; Wahlfors T; Schleutker J
    Eur J Cancer; 2013 Oct; 49(15):3335-43. PubMed ID: 23830236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27.
    Kouprina N; Pavlicek A; Noskov VN; Solomon G; Otstot J; Isaacs W; Carpten JD; Trent JM; Schleutker J; Barrett JC; Jurka J; Larionov V
    Genome Res; 2005 Nov; 15(11):1477-86. PubMed ID: 16251457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found.
    Hartikainen JM; Tuhkanen H; Kataja V; Dunning AM; Antoniou A; Smith P; Arffman A; Pirskanen M; Easton DF; Eskelinen M; Uusitupa M; Kosma VM; Mannermaa A
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):75-80. PubMed ID: 15668479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb.
    Camp NJ; Farnham JM; Allen-Brady K; Cannon-Albright LA
    Prostate; 2007 Sep; 67(13):1456-64. PubMed ID: 17654497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families.
    Bochum S; Paiss T; Vogel W; Herkommer K; Hautmann R; Haeussler J
    Prostate; 2002 Jun; 52(1):12-9. PubMed ID: 11992616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trimmed-haplotype test for linkage disequilibrium.
    MacLean CJ; Martin RB; Sham PC; Wang H; Straub RE; Kendler KS
    Am J Hum Genet; 2000 Mar; 66(3):1062-75. PubMed ID: 10712218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-chromosome as a marker for population history: linkage disequilibrium and haplotype study in Eurasian populations.
    Laan M; Wiebe V; Khusnutdinova E; Remm M; Pääbo S
    Eur J Hum Genet; 2005 Apr; 13(4):452-62. PubMed ID: 15657606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23.
    Xu J; Zheng SL; Hawkins GA; Faith DA; Kelly B; Isaacs SD; Wiley KE; Chang B; Ewing CM; Bujnovszky P; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
    Am J Hum Genet; 2001 Aug; 69(2):341-50. PubMed ID: 11443539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families.
    Kouprina N; Lee NC; Pavlicek A; Samoshkin A; Kim JH; Lee HS; Varma S; Reinhold WC; Otstot J; Solomon G; Davis S; Meltzer PS; Schleutker J; Larionov V
    Genes Chromosomes Cancer; 2012 Oct; 51(10):933-48. PubMed ID: 22733720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positional cloning by linkage disequilibrium.
    Maniatis N; Collins A; Gibson J; Zhang W; Tapper W; Morton NE
    Am J Hum Genet; 2004 May; 74(5):846-55. PubMed ID: 15048619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A haplotype at chromosome Xq27.2 confers susceptibility to prostate cancer.
    Yaspan BL; McReynolds KM; Elmore JB; Breyer JP; Bradley KM; Smith JR
    Hum Genet; 2008 May; 123(4):379-86. PubMed ID: 18350320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a prostate cancer susceptibility locus on the X chromosome.
    Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova GS; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi OP; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber JE; Bergh A; Jonsson BA; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
    Nat Genet; 1998 Oct; 20(2):175-9. PubMed ID: 9771711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.